Physician profile
Andrew B Wickline
NPI 1669459970
$578,722.62
in general payments reported to CMS, 2019-2025
29 companies · $159K in 2025
The $159K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,735 · 2020: $20K · 2021: $94K · 2022: $90K · 2023: $106K · 2024: $101K · 2025: $159K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $229K · Royalty Or License: $118K · Travel and Lodging: $15K · Food and Beverage: $3,268 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $228,843.00 |
| Royalty Or License | $118,125.57 |
| Travel and Lodging | $15,298.91 |
| Food and Beverage | $3,268.16 |
| Education | $179.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $493,698.94 | 2020-2025 | Gmk Sphere, Must, Quadra |
| Pacira Pharmaceuticals Incorporated | $28,420.07 | 2019-2025 | Exparel, Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $15,693.57 | 2024-2025 | |
| Avanos Medical | $13,594.76 | 2019-2021 | |
| Medical Device Business Services, INC. | $11,314.55 | 2019-2023 | |
| Next Science LLC | $6,512.41 | 2022-2025 | Xperience, Blastx, Surgx |
| Stryker Corporation | $4,759.82 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $2,363.74 | 2020-2022 | |
| Smith+Nephew, INC. | $501.51 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $376.19 | 2022-2025 | Comprehensive Shoulder System, Mymobility Platform |
| Horizon Therapeutics Plc | $287.19 | 2019-2020 | |
| Encore Medical, Lp | $259.77 | 2019-2020 | |
| Vertos Medical, INC. | $135.91 | 2022 | |
| Think Surgical, INC. | $133.17 | 2025 | |
| Restor3d, INC. | $102.05 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $98.26 | 2022 | |
| Medtronic, INC. | $93.93 | 2021 | |
| Orthalign INC | $87.70 | 2019 | |
| Pacira Therapeutics, INC. | $72.37 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $66.28 | 2019-2021 | |
| Heron Therapeutics, INC. | $24.12 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.03 | 2022 | |
| Baudax Bio INC. | $19.68 | 2022 | |
| Spr Therapeutics, INC | $17.26 | 2025 | Sprint Pns System |
| Springworks Therapeutics, INC. | $15.99 | 2025 | Ogsiveo |
| Convatec INC. | $13.05 | 2019 | |
| Bioventus LLC | $12.87 | 2021 | |
| Csl Behring | $12.09 | 2019 | |
| Endo Pharmaceuticals INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wickline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.